Erasmus School of Health Policy & Management
Visiting fellow | Health Economics (HE)
- l.timmers@eshpm.eur.nl
More information
Work
- Jesper T. Dros, Isabelle Bos, Christel E. van Dijk, Bert R. Meijboom, E. J.E. van der Hijden, L. Timmers & Robert A. Verheij (2025) - Shifting care from hospitals to general practice from the health insurers’ perspective: an interview study - Bmc Health Services Research, 25 (1) - doi: 10.1186/s12913-025-13650-4 - [link]
- Jan Willem Versteeg, Noraly Stam, Aukje K. Mantel-Teeuwisse, Lonneke Timmers, Wim Goettsch & Christine Leopold (2025) - Coverage with evidence development for medicines with insufficient evidence of clinical benefit: experience from the Netherlands - International Journal of Technology Assessment in Health Care, 41 (1) - doi: 10.1017/S0266462325103267 - [link]
- Anne Willemsen, Maureen van Molken, Riam al Dulaimi, Hedi Schelleman, Wim G. Goettsch & Lonneke Timmers (2025) - Preparing for the EU HTA Regulation: Insights from the Dutch Perspective - Journal of Market Access and Health Policy, 13 (3) - doi: 10.3390/jmahp13030035 - [link]
- Sibren van den Berg, Carolina E. Hollak, Lonneke Timmers & Samuel J. de Visser (2025) - Twenty-Four Years After the Launch of the EU Orphan Regulation: Analyzing Dutch Price Dynamics, Biosimilars, and Generics for Orphan Medicinal Products - Value in Health, 28 (5), 692-698 - doi: 10.1016/j.jval.2025.03.004 - [link]
- Michiel Zietse, Roelof W.F. van Leeuwen, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani, Jolanda E. de Boer, Rudy Dupree, Ron H.J. Mathijssen & Lonneke Timmers (2024) - Interchangeability of immune checkpoint inhibitors: an urgent need for action - The Lancet Oncology, 25 (11), e611-e616 - doi: 10.1016/S1470-2045(24)00212-2 - [link]
- R. Rozemeijer, W. P. van Bezouwen, N. D. van Hemert, J. A. Damen, S. Koudstaal, M. Stein, G. E. Leenders, L. Timmers, A. O. Kraaijeveld, K. Roes, P. Agostoni, P. A. Doevendans, P. R. Stella & M. Voskuil (2021) - Direct comparison of predictive performance of PRECISE-DAPT versus PARIS versus CREDO-Kyoto: a subanalysis of the ReCre8 trial - Netherlands Heart Journal, 29 (4), 201-214 - doi: 10.1007/s12471-020-01486-y - [link]
